DSM commences tender offer for Martek Biosciences Corp

Royal DSM N.V. said its indirect wholly-owned subsidiary, Greenback Acquisition Corp, has commenced its tender offer for all outstanding shares of common stock of Martek Biosciences Corp at a price of $31.50 per share.

The tender offer is being made in connection with the Agreement and Plan of Merger, dated as of 20 December 2010, by and among DSM, Greenback Acquisition Corporation and Martek, which DSM and Martek announced a day later.